Mangangot, Mark Caleb R.
HRN: 24-14-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2025
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
01/18/2025
01/23/2025
PO
1.6 Ml
OD
T/C Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes